FDA Names Frueh Head Of Pharmacogenomics Review Group
This article was originally published in The Pink Sheet Daily
Executive Summary
Felix Frueh, PhD, is associate director of genomics in CDER’s Office of Clinical Pharmacology & Biopharmaceutics and head of FDA’s new Interdisciplinary Pharmacogenomics Review Group. The agency continues to recruit staff for the IPRG.